Literature DB >> 24119367

The utility of middle cerebral artery clot density and burden assessment by noncontrast computed tomography in acute ischemic stroke patients treated with thrombolysis.

Mehmet A Topcuoglu1, E Murat Arsava2, Oguzhan Kursun3, Erhan Akpinar4, Bulent Erbil5.   

Abstract

BACKGROUND: Quantitative and qualitative evaluation of middle cerebral artery (MCA) density, together with extent of thrombi, was assessed on plain computerized tomography (CT) to delineate better the prognostic value of the hyperdense MCA sign (HMCAS) in a cohort of patients who underwent intravenous or intra-arterial thrombolysis.
METHODS: Density of MCA was quantified by maximum pixel-sized measurement of Hounsfield unit (HU) in 105 patients with acute MCA proximal segment occlusion, 15 patients with vertebrobasilar circulation stroke (VBS) and 44 nonstroke control subjects. Predictive value of HMCAS, absolute HU value of within MCA, side-to-side HU ratio, and difference along with a newly introduced hyperdense MCA burden score in early dramatic recovery (EDR) and third-month favorable prognosis were determined with multivariate adjustment for age, baseline stroke severity, and thrombus length as measured on CT angiography. Receiver operator characteristics (ROC) curves were used to determine the cutoffs of quantitative indices to determine HMCAS and their prognostic significance.
RESULTS: Higher HU was present in the ipsilateral MCA of the patients compared with their contralateral side and basilar tip and any MCA of VBS stroke and control subjects (area under the curve [AUC] of ROC curves was .753). Symptomatic-to-asymptomatic HU difference and ratio of MCA stroke were also significantly higher than side-to-side difference calculated in VBS stroke and control groups (AUC of ROC curves: .770 and .764, respectively). Optimal thresholds of absolute HU (44), side-to-side HU difference (2), and ratio (1.0588) showed borderline sensitivity and specificity. HMCAS and its quantitative indices were not significantly associated with EDR and favorable third-month outcome. Furthermore, there was no difference in terms of cardioembolic and atherothrombotic thrombi HU.
CONCLUSIONS: Utility of the HMCAS as a prognostic marker in stroke thrombolysis is not high in the CT angiography era. Previous observation regarding its positive prognostic role can be attributed to its association with proximal location and extent of clot burden, which are detectable reliably with current CT angiography techniques. Neither quantification nor extent of increased density seems to have clinical utility for treatment decision making in MCA strokes and prediction of emboli composition and response to recanalization attempt.
Copyright © 2014 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hounsfield unit; attenuation; computerized tomography; middle cerebral artery; prognosis; stroke

Mesh:

Substances:

Year:  2013        PMID: 24119367     DOI: 10.1016/j.jstrokecerebrovasdis.2013.08.026

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  14 in total

Review 1.  Insights from thrombi retrieved in stroke due to large vessel occlusion.

Authors:  Marco Bacigaluppi; Aurora Semerano; Giorgia Serena Gullotta; Davide Strambo
Journal:  J Cereb Blood Flow Metab       Date:  2019-06-18       Impact factor: 6.200

2.  Heterogeneity between proximal and distal aspects of occlusive thrombi on pretreatment imaging in acute ischemic stroke.

Authors:  Tetsuya Hashimoto; Takenobu Kunieda; Tristan Honda; Fabien Scalzo; Latisha K Sharma; Jason D Hinman; Neal M Rao; May Nour; Mersedeh Bahr-Hosseini; Jeffrey L Saver; Radoslav Raychev; David S Liebeskind
Journal:  Neuroradiol J       Date:  2021-10-05

Review 3.  Radiology-Pathology Correlations of Intracranial Clots: Current Theories, Clinical Applications, and Future Directions.

Authors:  J C Benson; D F Kallmes; A S Larson; W Brinjikji
Journal:  AJNR Am J Neuroradiol       Date:  2021-07-22       Impact factor: 4.966

4.  Prognostic capacity of hyperdense middle cerebral artery sign in anterior circulation acute ischaemic stroke patients receiving reperfusion therapy: a systematic review and meta-analysis.

Authors:  Chenyu Shi; Murray C Killingsworth; Sonu Menachem Maimonides Bhaskar
Journal:  Acta Neurol Belg       Date:  2021-06-06       Impact factor: 2.471

5.  Stroke Mechanism in COVID-19 Infection: A Prospective Case-Control Study.

Authors:  Mehmet Akif Topcuoglu; Mehmet Yasir Pektezel; Dogan Dinç Oge; Nihal Deniz Bulut Yüksel; Cansu Ayvacioglu; Ezgi Demirel; Sinan Balci; Anil Arat; Seda Banu Akinci; Ethem Murat Arsava
Journal:  J Stroke Cerebrovasc Dis       Date:  2021-06-01       Impact factor: 2.136

6.  Effect of X-Ray Attenuation of Arterial Obstructions on Intravenous Thrombolysis and Outcome after Ischemic Stroke.

Authors:  Grant Mair; Rüdiger von Kummer; Richard I Lindley; Peter A G Sandercock; Joanna M Wardlaw
Journal:  PLoS One       Date:  2015-12-23       Impact factor: 3.240

7.  Observer variability of absolute and relative thrombus density measurements in patients with acute ischemic stroke.

Authors:  Emilie M M Santos; Albert J Yoo; Ludo F Beenen; Olvert A Berkhemer; Mark D den Blanken; Carrie Wismans; Wiro J Niessen; Charles B Majoie; Henk A Marquering
Journal:  Neuroradiology       Date:  2015-10-22       Impact factor: 2.804

8.  Added value of multiphase CTA imaging for thrombus perviousness assessment.

Authors:  E M M Santos; C D d'Esterre; K M Treurniet; W J Niessen; M Najm; M Goyal; A M Demchuk; C B Majoie; B K Menon; H A Marquering
Journal:  Neuroradiology       Date:  2017-09-30       Impact factor: 2.804

9.  Manual Thrombus Density Measurement Depends on the Method of Thrombus Delineation.

Authors:  Liang Shu; Johannes Meyne; Olav Jansen; Ulf Jensen-Kondering
Journal:  J Stroke       Date:  2018-09-30       Impact factor: 6.967

10.  Stroke Lateralization in Large Hemisphere Infarctions: Characteristics, Stroke-Related Complications, and Outcomes.

Authors:  Jie Li; Ping Zhang; Yingying Liu; Wanli Chen; Xingyang Yi; Chun Wang
Journal:  Front Neurol       Date:  2021-12-10       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.